newsfilter
← Latest News
Business Wire·

Revvity and Profluent Collaborate to Launch AI-Enhanced Adenine Deaminase Pin-point Base Editing Systems

Combination of Revvity's proprietary Pin-point platform and Profluent's AI-engineered proteins created to inspire accelerated development of novel gene editing therapies Revvity, Inc. (NYSE:RVTY) announced a strategic